Liquent VP of sales and marketing Jeff Huntsman told Outsourcing-pharma that drug firms often lack in-house capacity to effectively manage the production of regulatory documents and that was a key driver for the deal with electronic submissions specialist Take Solutions.
He explained the alliance combines Liquent's regulatory expertise with Take's existing infrastructure to provide efficiencies adding that "Take is a very strong partner from a standpoint of having offshore resources and [of working within] compliance and efficiency guidelines."
Huntsman went on to say that Liquent is seeing considerable demand from regulatory services from large pharma firms, particularly for “non-strategic” products where the challenge is to produce the required regulatory documents in as efficient a way as possible.
He also said that, while this market is strong in Europe and the US, Asia has been slower to adapt to the eCTD model and as a result there has been less demand for outsourced submissions solutions.
